Data fra kliniske undersøgelser indikerer, at der er en tendens til, at proportionen af behandlinger forbundet med dysfagi øges med højere doser injiceret ind i nakkemusklen.
Data from clinical studies indicate that there is a tendency for the proportion of treatments associated with dysphagia to increase with higher doses injected into the sternocleidomastoid muscle.